Your browser doesn't support javascript.
loading
Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li, Hongyi; Tu, Jian; Zhao, Zhiqiang; Chen, Lijuan; Qu, Yueting; Li, Hongbo; Yao, Hao; Wang, Xiaoshuai; Lee, Dung-Fang; Shen, Jingnan; Wen, Lili; Huang, Gang; Xie, Xianbiao.
Afiliação
  • Li H; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Tu J; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou, China.
  • Zhao Z; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Chen L; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Qu Y; OrigiMed, Co., Ltd., Shanghai, China.
  • Li H; OrigiMed, Co., Ltd., Shanghai, China.
  • Yao H; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Wang X; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Lee DF; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Shen J; Department of Integrative Biology & Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston.
  • Wen L; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Huang G; Department of Anesthesiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, P. R. China.
  • Xie X; Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Theranostics ; 10(21): 9477-9494, 2020.
Article em En | MEDLINE | ID: mdl-32863940

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Sarcoma / Inibidores de Poli(ADP-Ribose) Polimerases / Indazóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Theranostics Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Sarcoma / Inibidores de Poli(ADP-Ribose) Polimerases / Indazóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Theranostics Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Austrália